Faecal calprotectin levels, C-reactive protein levels and partial Mayo score as early predictors of clinical and endoscopic outcomes in adult patients with moderately to severely active ulcerative colitis treated with tofacitinib in a Phase 2 study
Marla C. Dubinsky 1
David P. Hudesman 2
nicole kulisek 3
Leonardo Salese 3
Jerome Paulissen 4
Chinyu Su 3
Fernando Magro 5
1 Icahn School of Medicine at Mount Sinai,New York, NY,United States
2 New York University,New York, NY,United States
3 Pfizer Inc,Collegeville, PA,United States
4 Syneos Health,Morrisville, NC,United States
5 University of Porto and Centro Hospitalar São
Session
IBD I (Posters)
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]